07.22.19
On June 24, 2019, President Donald Trump issued an “Executive Order on Improving Price and Quality Transparency in American Healthcare to Put Patients First.”
The pediatric channel provides a unique opportunity to reach parents and their children during the first three years of life.
Any time a company is engaged in content marketing—whether it is creating content itself or acting through influencers—it is important to be cognizant of intellectual property (IP) issues.
On July 9, Judge Amit P. Mehta of the U.S. District Court, District of Columbia vacated an administration final rule that would have required drug manufacturers to disclose wholesale acquisition prices in their television broadcast advertising.
Before addressing legal requirements and compliance practices, it is important to understand the terminology used in discussing prize promotions.
Dual eligibles—those eligible for both Medicare and Medicaid—are among the most costly and complex enrollees in both programs.
07.09.19
High out-of-pocket costs can be a significant barrier to access for Part D enrollees, especially for non-low-income subsidy (LIS) enrollees with a condition that requires an expensive specialty drug for treatment.
06.25.19
In May 2018, the President and the Department of Health & Human Services (HHS) rolled out the Drug Pricing Blueprint, outlining the administration’s agenda for dealing with high drug prices.
There have been a number of health plan transactions over the past year, but we’ve seen a shift in the types of deals.
It is no surprise that healthcare data breaches are on the rise.